Harness stewards’ inquiry – Trainer Cody Walldrodt
Racing WA stewards have been advised by the Chem Centre in Perth that flunixin has been detected in the sample taken from Lombo Ishak prior to it trialling in trial three at Pinjarra Paceway on 1 November 2023.
These findings have been verified by the Australian Racing Forensic Laboratory (NSW).
Accordingly, the stewards will inquire into these reports on Wednesday,13 March 2024. The trainer Mr Walldrodt has been directed to attend.
Flunixen is a nonsteroidal anti-inflammatory (NSAID) used as a common prescription veterinary medicine in racing with anti-inflammatory and analgesic effects.